Author/s: Orkaby, A.R., Driver, J.A., Ho, Y., et al.
Importance: Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in adults 75 years and older.
Objective: To evaluate the role of statin use for mortality and primary prevention of ASCVD in...
Author/s: Tarter, R.E., Kirisci, L., Reynolds, M., Seybert, A., Cochran, C., Vanyukov, M.
Objective
t To evaluate the accuracy of detecting 16 year old male (N=465) and female (N=162) youths who subsequently manifest opioid use disorder (OUD) at 25 years of age. We hypothesized that the combined measures of two components of etiology, heritable risk and substance use...
Author/s: Qin, X., Corle, M.E., Yang, L., Liang, J., Wang, K., Guo, X., Zhang, A.L., Mao, L., Lu, C., Xue, C.C., Liu, X.
Abstract
Background: Increasing antibiotic resistance has motivated interest in non-antibiotic prophylaxis of recurrent urinary tract infections (rUTI).
Objectives: To conduct a systematic review of the current state of evidence of acupuncture for...
Author/s: Yao, T., Huang, Y., Chang, S., Tsai, S., Wu, A.C., Tsai, H.
Abstract
Background: Long-term use of oral corticosteroids has known adverse effects, but the risk from brief oral steroid bursts (≤14 days) is largely unknown.
Objective: To examine the associations between steroid bursts and severe adverse events...
Author/s: Feldstein, L.R., et al.
Abstract
BACKGROUND
Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome....
Author/s: Patel, T.K., Barvaliya, M, Kevadiya, B.D., Patel, P.B., Bhalla, H.L.
Hydroxychloroquine has been promoted for its use in treatment of COVID-19 patients based on in-vitro evidences. We searched the databases to include randomized and observational studies evaluating the effect of Hydroxychloroquine on mortality in COVID-19 patients. The outcome was summarized as...
Author/s: Bondalevich, L., Laplante, S.
Author/s: Nelson, N.P., Weng, M.K., Hofmeister, M.G., Moore, K.L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J.R., Harris, A.M.
HEPATITIS A IS A VACCINE-PREVENTABLE, COMMUNICABLE DISEASE OF THE LIVER CAUSED BY THE HEPATITIS A VIRUS (HAV). THE INFECTION IS TRANSMITTED VIA THE FECAL-ORAL ROUTE, USUALLY FROM DIRECT PERSON-TO-PERSON CONTACT OR CONSUMPTION OF CONTAMINATED FOOD OR WATER. HEPATITIS A IS AN ACUTE, SELF-LIMITED...
Author/s: Gunn, R., Ferrara, L.K., Dickinson, C., Fagnan, L.J., Carney, P.A., Davis, M.M.
Author/s: Causada-Calo, N., Bishay, K., Albashir, S., Mazroui, A.A., Armstrong, D.
Abstract
Importance: There are insufficient data describing the incidence and risk factors of postcolonoscopy complications in older individuals.
Objective: To assess the association between older age (≥75 years) and the risk of postcolonoscopy...